We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Fluorescent Technique Allows Quantitative Measurement of Cell Membrane Lipids

By LabMedica International staff writers
Posted on 25 Oct 2011
A recent paper described the development of a method for the in situ quantification of cell membrane lipids, which are important signaling elements that have been linked to certain disease states, inflammation, and the immune response system.

The current study is among the first to describe a quantitative method for measuring lipid concentration in the membrane of a living cell. More...
To accomplish this task investigators at the University of Illinois (Chicago, USA) used a new chemical method to label proteins with an environmentally sensitive fluorophore. A prototype sensor for the lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) - a key signaling lipid in diverse cellular processes - was generated by covalently attaching a single 2-dimethylamino-6-acyl-naphthalene group to the N-terminal alpha-helix of the engineered epsin1 ENTH domain, a protein that selectively binds PtdIns(4,5)P2.

Results reported in the October 9, 2011, online edition of the journal Nature Chemistry revealed that tracking the signal generated by binding of the fluorescent protein to this key signaling lipid allowed robust and sensitive in situ quantitative imaging in mammalian cells that provided new insight into the dynamics and fluctuation of the lipid within the microenvironment of the cell membrane.

“Lipid molecules on cell membranes can act as switches that turn on or off protein-protein interactions affecting all cellular processes, including those associated with disease," said senior author Dr. Wonhwa Cho, professor of chemistry at the University of Illinois. “While the exact mechanism is still unknown, our hypothesis is that lipid molecules serve sort of like a sliding switch. It is not just the presence of lipid, but the number of lipid molecules that are important for turning on and off biological activity.”

“We had to engineer the protein in such a way to make it very stable, behave well, and specifically recognize a particular lipid,” said Dr. Cho. “We would like to be able to measure multiple lipids, simultaneously. It would give us a snapshot of all the processes being regulated by the different lipids inside a cell.”

Related Links:
University of Illinois


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Urine Analyzer
respons® UDS100
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.